obesity notes

Obesity, Metabolic Syndrome

Statistics

  • According to the CDC estimates:
      - 32% of adult men are classified as obese.
      - 35% of adult women are classified as obese.
      - Overall estimates of overweight and obesity show:
        - 72% for men
        - 64% for women
      - This indicates that over two-thirds of the U.S. male and female populations require intervention for weight loss and management.

Overweight Measures

  • Definitions of overweight and obesity:
      - Overweight: 20% or more over ideal body weight.
      - Obesity: 30% or more over ideal body weight.
      - Morbid obesity: 40% or more over ideal body weight.

Adipose Cells

  • Adipose cells can:
      - Increase in number (hyperplasia)
      - Hypertrophy to increase fat mass

  • Major areas of fat storage include:
      - Subdermal tissue (subcutaneous)
      - Omentum (covering over the intestines and over the organs, referred to as visceral fat)

Subcutaneous Fat (SBC) and Visceral Fat (VSC)

  • Risk assessment based on fat types:
      - SBC (Subcutaneous Fat) - Lowest Risk
      - VSC (Visceral Fat) - Moderate Risk
      - Higher levels of VSC are correlatively associated with the highest health risks.

Obesity Genes

  • Numerous gene loci are under investigation as potential “obesity genes.”
      - In obese children, 5% exhibit mutations at genes located on chromosomes 2p23 and 18q21.3.
      - Individuals lacking the leptin gene or having mutations at 7q31 related to the leptin receptor are prone to obesity.
      - Genetic modifications due to mutations at 5q15-21 can lead to significant obesity.
      - Severe obesity is also correlated with mutations in an adipocyte transcription factor gene located at 3p25.

Adipokines

  • Adipocytes, which are metabolically active, secrete a variety of substances known as adipokines, including:
      - Tumor necrosis factor alpha (TNF-alpha)
      - Interleukin-6 (IL-6)
      - Angiotensinogen (AGT)
      - Plasminogen Activator Inhibitor (PAI)
      - Adiponectin
      - Leptin
      - Resistin

Adiponectin

  • Functions and effects of adiponectin:
      - Enhances cellular sensitivity to insulin.
      - Exerts anti-inflammatory effects.
      - Protective against the formation of arteriosclerosis.
      - Described as a “good” adipokine.
      -

  • Relationship with fat content:
      - Inverse correlation with body adiposity: the higher the adiposity, the lower the adiponectin levels.

Leptin

  • Leptin production is influenced by fat levels; an increase in fat results in an increase of leptin.

  • Functions of leptin:
      - Signals the brain regarding satiety.
      - In obese individuals, there is often resistance to leptin leading to a decreased feeling of satiety after meals.
      - Works in conjunction with adiponectin to enhance cellular insulin sensitivity, reduce triglyceride levels, and inhibit fat accumulation.
      - Also categorized as a “good” adipokine.

Resistin

  • Effects of resistin:
      - Induces insulin resistance.
      - Enhances hepatic glucose production.
      - Raises triglyceride levels, reduces HDL levels, and contributes to endothelial dysfunction, predisposing individuals to early arteriosclerosis formation.
      - Classified as a “bad” adipokine.

Angiotensinogen (AGT)

  • Production and effects of AGT:
      - Secreted from adipose tissue, increases vascular tone.
      - High AGT levels contribute to hypertension and vascular changes indicative of arteriosclerosis.
      - Considered a “bad” adipokine.

Plasminogen Activator Inhibitor (PAI)

  • Role of PAI:
      - Produced by adipose tissue; it inhibits tissue plasminogen activator (tPA), which is responsible for dissolving clots.
      - High levels of PAI inhibit fibrinolysis and promote clot formation, especially in obesity.

Pathophysiological Effects of Excess Adipose Tissue

  • Increased free fatty acids, reduced pancreatic insulin, and organ damage are observed in excessive fat conditions.

  • Increased levels of TNF-alpha and IL-6 due to heightened lipolysis and free fatty acids lead to further pancreatic degeneration.

  • Increased leptin resistance contributes to dyslipidemia and insulin resistance.

  • Decreased adiponectin results in worse insulin resistance and dyslipidemia.

  • Elevated AGT and PAI from adipose tissue enhances clot formation and raises blood pressure.

  • Increased resistin correlates with insulin resistance and dyslipidemia.

Cardiovascular Disease Risk

  • A greater number of fat cells is associated with an increased risk of cardiovascular disease due to adipose tissue secretion of harmful adipokines, AGT, and PAI.

Ghrelin

  • Functions of ghrelin:
      - Peptide secreted by the stomach, stimulates hunger.
      - Regulates food intake and stimulates growth hormone release.

  • Pathological considerations regarding ghrelin are highlighted:
      - Insensitivity of Growth Hormone Secretagogue Receptor (GHS-R) might occur.
      - Altered signaling could involve the blood-brain barrier (BBB) transfer issues, GH, and IGF-1 interactions.

  • Regions affected include the hypothalamus, liver, pancreas, and gastric system, with implications for gastric motility, gastric emptying, and overall glycemia management.